Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis (Next GeneSiS-Trial) - Study Protocol for a Prospective, Observational, Non-interventional, Multicenter, Clinical Trial

NCT03356249 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT03356249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03356249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis (Next GeneSiS-Trial) - Study Protocol for a Prospective, Observational, Non-interventional, Multicenter, Clinical Trial
Lead sponsor
University Hospital Heidelberg
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
September 30, 2021
Enrollment
500 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock